A clinically significant decrease in the frequency of incontinence , which we defined as a relative reduction in the percent of checks wet of > 33 % , occurred in 20 subjects ( 32 % ) while on active drug and in 12 subjects ( 19 % ) while on placebo ( P = .48 by chi-square ) .
